Orphan Drugs Need Separate Category In Medicare Formularies, BIO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Biotechnology Industry Organization is advocating the creation of a separate category for orphan drugs within Medicare drug plan formularies